Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Receptor-type tyrosine-protein phosphatase U (PTPRU) is a cell surface receptor protein encoded by the human PTPRU gene. It is part of the R2B subfamily of receptor-type protein tyrosine phosphatases and features extracellular domains enabling cell-cell interactions, as well as two intracellular phosphatase domains. Unlike typical receptor-type PTPs, structural and biochemical studies show both PTPRU domains lack phosphatase activity and instead function as pseudophosphatase scaffolds. PTPRU regulates cellular processes—not by dephosphorylation but by protecting shared substrates from dephosphorylation, fine-tuning cell junction formation, growth, differentiation, and signaling, and is involved in pathological contexts including tumor progression
Scaffold or substrate competitor, not enzymatic dephosphorylation Functions as a negative regulator by sequestering protein substrates such as β-catenin from active phosphatases, thereby protecting phosphotyrosine states relevant to cell adhesion and signal transduction
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Receptor-type tyrosine-protein phosphatase U (PTPRU).